Fermion and Simcere Enter into an Exclusive License and Collaboration Agreement for China's First SSTR4 Agonist Targeting Pain
Guangzhou Fermion Technology Co., Ltd. and Simcere Pharmaceutical Group Limited (HKEX: 2096) have announced a partnership to develop a clinical-stage pain treatment asset, FZ002-037, targeting SSTR4.
中国日报网9h
Sport conference taps opportunities from National Games for Greater Bay Area
A sport industry innovation conference focusing on the 15th National Games and development of the Guangdong-Hong Kong-Macao ...
Guangzhou noodle shops, Mandarin in Tibet in focus as China pushes ethnic integration
Latest publication by National Ethnic Affairs Commission hails Guangzhou for creating China’s first big data set to promote ...
Hong Kong’s historic cross-border train to be showcased at MTR exhibition
Intercity KTT train service ran for decades between Hong Kong and Guangzhou, before being replaced by high-speed rail.
birmingham.ac.uk22h
University of Birmingham welcomes Year of the Snake with magical concert
Internationally acclaimed Chinese pianist Di Xiao took to the stage at the University of Birmingham with a talented company ...